Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer

J Clin Oncol. 2008 Mar 10;26(8):1198-200. doi: 10.1200/JCO.2007.14.8734.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Prognosis
  • Receptor, ErbB-2 / metabolism
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Receptor, ErbB-2
  • Trastuzumab